Holmes Biopharma, Inc. (LMB) Misses Q1 EPS by 65c, Slight Beat on Revenues; Boosts FY19 Revenue Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. BA
6. SPY
7. META
8. HOOD
9. INTC
10. JBLU

Go back to Holmes Biopharma, Inc. (LMB) Misses Q1 EPS by 65c, Slight Beat on Revenues; Boosts FY19 Revenue Outlook

Limbach Holdings Reports First Quarter 2018 Results

May 15, 2018 4:15 PM EDT

Q1 2018 Revenues of $120.5 Million; Construction Revenues of $96.8 Million

Conference Call Scheduled for 9:00am ET Wednesday May 16, 2018

PITTSBURGH--(BUSINESS WIRE)-- Limbach Holdings, Inc. (NASDAQ: LMB) (Limbach or the Company) today announced financial results for the quarter ended March 31, 2018. Total revenues increased 4.7% versus the prior year period to $120.5 million in the first quarter of 2018. Construction segment revenue of $96.8 million grew 5.8% from the prior year period while Service segment revenues were flat at $23.7 million.

Other key financial highlights of the quarter included:

... More